These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6800808)

  • 41. Determinants of acute and long-term response to converting enzyme inhibitors in congestive heart failure.
    Levine TB; Cohn JN
    Am Heart J; 1982 Nov; 104(5 Pt 2):1159-64. PubMed ID: 6182784
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of captopril on pulmonary arterial hypertension in congestive heart failure associated with chronic obstructive bronchopneumopathy].
    Saadjian A; Philip-Joet F; Allard-Latour G; Arnaud A; Torresani J
    Rev Pneumol Clin; 1984; 40(5):321-5. PubMed ID: 6395282
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined vasodilator therapy for chronic congestive heart failure.
    Cody RJ; Franklin KW; Laragh JH
    Am Heart J; 1983 Apr; 105(4):575-80. PubMed ID: 6340448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Captopril in refractory heart failure: clinical and hemodynamic observations.
    Abinader EG; Sharif D; Rosenfeld T; Malouf S
    Cardiology; 1983; 70(6):326-32. PubMed ID: 6370433
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers.
    Shepherd AN; Campbell BC; Reid JL
    J Cardiovasc Pharmacol; 1982; 4(3):381-7. PubMed ID: 6177933
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative immediate hemodynamic and hormonal effects of amrinone and captopril in patients with severe chronic heart failure.
    Packer M; Medina N; Yushak M
    Am J Med Sci; 1986 Jan; 291(1):8-15. PubMed ID: 3510545
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
    Turini GA; Waeber B; Brunner HR
    Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the effect of renin inhibition and angiotensin-converting enzyme inhibition in ovine heart failure.
    Fitzpatrick MA; Rademaker MT; Charles CJ; Yandle TG; Espiner EA; Ikram H; Nussberger J
    J Cardiovasc Pharmacol; 1992 Feb; 19(2):169-75. PubMed ID: 1376784
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Captopril affects blood pressure equally in renovascular and essential hypertension and in the fluid-depleted anephric state.
    de Bruyn JH; Wenting GJ; Man in 'T Veld AJ; Derkx FH; Schalekamp MA
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():83s-86s. PubMed ID: 7004742
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Haemodynamic effects of frusemide and its influence on repetitive rapid volume loading in acute myocardial infarction.
    Nelson GI; Ahuja RC; Silke B; Okoli RC; Hussain M; Taylor SH
    Eur Heart J; 1983 Oct; 4(10):706-11. PubMed ID: 6653580
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Determination of the optimal dose of captopril in the treatment of severe cardiac failure by hourly hemodynamic monitoring].
    Allal J; Pornin M; Rossi F; Poupet JY; Bordage JP; Barraine R
    Arch Mal Coeur Vaiss; 1984 Apr; 77(4):458-67. PubMed ID: 6426432
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
    Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
    Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute filling pattern changes of the failing left ventricle after captopril as related to ventricular structure.
    Barbier P; Tamborini G; Alioto G; Pepi M
    Cardiology; 1996; 87(2):153-60. PubMed ID: 8653733
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Haemodynamic dose-response effects of intravenous amrinone in left ventricular failure complicating acute myocardial infarction.
    Verma SP; Silke B; Reynolds GW; Hafizullah M; Jackson NC; Taylor SH
    J Cardiovasc Pharmacol; 1985; 7(6):1101-6. PubMed ID: 2418295
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and haemodynamic responses to captopril and hydralazine in chronic congestive heart failure: the importance of preload reduction.
    Fitzgerald DJ; O'Callaghan WG; O'Malley K; Horgan J; O'Brien E
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):217S-222S. PubMed ID: 6753903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanisms involved in cardiac enlargement and congestive heart failure development after acute myocardial infarction.
    Kleber FX; Nussberger J; Niemöller L; Doering W
    Cardiology; 1992; 81(4-5):213-20. PubMed ID: 1301246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics and haemodynamic effects of tocainide in patients with acute myocardial infarction complicated by left ventricular failure.
    MacMahon B; Bakshi M; Branagan P; Kelly JG; Walsh MJ
    Br J Clin Pharmacol; 1985 Apr; 19(4):429-34. PubMed ID: 3922392
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Acute and long-term effect of captopril in severe chronic heart failure].
    Kikis D; Heck I; Stumpe KO; Esser H
    Dtsch Med Wochenschr; 1985 Apr; 110(15):583-8. PubMed ID: 2983968
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.
    Romankiewicz JA; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Jan; 25(1):6-40. PubMed ID: 6218982
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hemodynamic and regional blood flow response to captopril in congestive heart failure.
    Levine TB; Olivari MT; Cohn JN
    Am J Med; 1984 May; 76(5B):38-42. PubMed ID: 6375361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.